LabCompass

Patrick Ruz

Medicine · The Ohio State University

OpenAlex
Early career · publishing since 2020
Chemotherapy-induced cardiotoxicity and mitigationChronic Lymphocytic Leukemia ResearchPI3K/AKT/mTOR signaling in cancerChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research

Publications

31

Citations

448

Est. group size

~23

Recurring co-author estimate

Active years

6

Publishing since 2020

Research summary
AI-generated

Patrick Ruz works in cardio-oncology, a field studying how cancer treatments—especially targeted drugs used for blood cancers like leukemia—can affect the heart and blood vessels. His work includes case studies of heart complications from specific cancer drugs (such as tyrosine kinase inhibitors) and broader reviews of heart disease risk following cancer therapies like radiotherapy.

Cardio-oncology (heart effects of cancer treatment)Leukemia treatment side effectsTyrosine kinase inhibitor cardiotoxicityRadiotherapy-related cardiovascular diseaseCardiac complications in cancer patients

Publication output began around 2020 and increased through 2022, remaining fairly steady at 4-7 papers per year through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.6/year recently
1718192020: 3 publications202021: 5 publications212022: 7 publications7222023: 6 publications232024: 6 publications242025: 4 publications2526
Recent publications
Publishes in
  • Circulation×8
  • Blood×2
  • JAMA Oncology×2
  • Journal of the American College of Cardiology×2
  • Current Developments in Nutrition×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile